Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double‐Blind, Placebo‐Controlled, Pilot Trial

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles